AstraZeneca to invest $2 billion in Maryland manufacturing expansion
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
India presents one of the world’s largest untapped opportunities for neurovascular screening
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
The investment in land is Rs. 19.85 crore
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
Subscribe To Our Newsletter & Stay Updated